F1SCHEDULE 3Sampling and analysis

Annotations:
Amendments (Textual)

F1PART 3Monitoring for indicative dose and analytical performance characteristics

Screening strategies for gross alpha activity and gross beta activityF19

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .